Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099

Profile

Prof Mickey KOH

Principal Investigator

Prof Mickey Boon Chai Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP) in London. He obtained his PhD in the area of T cell immunotherapy in transplantation by the University of London in 2000

He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School. He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine. He has in the past also had the concurrent appointment of Deputy Director of the National Blood Service in Singapore

Prof Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation (WHO) and sits on the Expert Committee on Biological Standardisation.

He is the current President of the Worldwide Network for Blood and Marrow Transplantation (WBMT), sits on the Board of Directors for ICCBBA and is a past Board member of the International Society of Cellular Therapy (ISCT).

Prof Koh is the chief external examiner for the post graduate haematology training at the University of West Indies and also a visiting professor with the Medical University of Taipei.

UK

Principal Investigators

BloodCounts!

Key Publications

Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies. Gabriel C, …, Koh MBC. Vox Sang. 2023 Apr;118(4):301-309. doi: 10.1111/vox.13413. Epub 2023 Feb 27. PMID: 36847186.

Prioritising health equity alongside donation safety, Koh MBC, et al., Lancet Haematol. 2022 Nov;9(11):e803-e804. doi: 10.1016/S2352-3026(22)00302-7. Epub 2022 Sep 22. PMID: 36156201.

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Tokaz MC et al., Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013. Epub 2022 Dec 23. PMID: 36572384.

Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Correa C et al., Bone Marrow Transplant. 2022 Jun;57(6):881-888. doi: 10.1038/s41409-022-01630-9. Epub 2022 Mar 28. PMID: 35347244.

Laboratory/Pathology Services and Blood Bank, Fleming KM et al. The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 8. PMID: 36122099